Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10051115rdf:typepubmed:Citationlld:pubmed
pubmed-article:10051115lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C0003842lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C0039259lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C0028351lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C0027825lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C1521797lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:10051115lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:10051115pubmed:issue1lld:pubmed
pubmed-article:10051115pubmed:dateCreated1999-5-3lld:pubmed
pubmed-article:10051115pubmed:abstractText1. The effects of Ca2+ concentration and Ca2+ channel blockers on noradrenaline (NA) and adenosine 5'-triphosphate (ATP) release from postganglionic sympathetic nerves have been investigated in rat tail arteries in vitro. Intracellularly recorded excitatory junction potentials (e.j.ps) were used as a measure of ATP release and continuous amperometry was used to measure NA release. 2. Varying the extracellular Ca2+ concentration similarly affected the amplitudes of e.j.ps and NA-induced oxidation currents evoked by trains of ten stimuli at 1 Hz. 3. The N-type Ca2+ blocker, omega-conotoxin GVIA (omega-CTX GVIA, 0.1 microM) reduced the amplitudes of both e.j.ps (evoked by trains of ten stimuli at 1 Hz) and NA-induced oxidation currents (evoked by trains of ten stimuli at 1 Hz and 50 stimuli at 10 Hz) by about 90%. 4. The omega-CTX GVIA resistant e.j.ps and NA-induced oxidation currents evoked by trains of 50 stimuli at 10 Hz were abolished by the non-selective Ca2+ channel blocker, Cd2+ (0.1 mM), and were reduced by omega-conotoxin MVIIC (0.5 microM) and omega-agatoxin IVA (40 nM). 5. Nifedipine (10 microm) had no inhibitory effect on omega-CTX GVIA resistant e.j.ps and NA-induced oxidation currents. 6. Thus both varying Ca2+ concentration and applying Ca2+ channel blockers results in similar effects on NA and ATP release from postganglionic sympathetic nerves. These findings are consistent with the hypothesis that NA and ATP are co-released together from the sympathetic nerve terminals.lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:languageenglld:pubmed
pubmed-article:10051115pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:citationSubsetIMlld:pubmed
pubmed-article:10051115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10051115pubmed:statusMEDLINElld:pubmed
pubmed-article:10051115pubmed:monthJanlld:pubmed
pubmed-article:10051115pubmed:issn0007-1188lld:pubmed
pubmed-article:10051115pubmed:authorpubmed-author:CunnaneT CTClld:pubmed
pubmed-article:10051115pubmed:authorpubmed-author:BrockJ AJAlld:pubmed
pubmed-article:10051115pubmed:issnTypePrintlld:pubmed
pubmed-article:10051115pubmed:volume126lld:pubmed
pubmed-article:10051115pubmed:ownerNLMlld:pubmed
pubmed-article:10051115pubmed:authorsCompleteYlld:pubmed
pubmed-article:10051115pubmed:pagination11-8lld:pubmed
pubmed-article:10051115pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:meshHeadingpubmed-meshheading:10051115...lld:pubmed
pubmed-article:10051115pubmed:year1999lld:pubmed
pubmed-article:10051115pubmed:articleTitleEffects of Ca2+ concentration and Ca2+ channel blockers on noradrenaline release and purinergic neuroeffector transmission in rat tail artery.lld:pubmed
pubmed-article:10051115pubmed:affiliationPrince of Wales Medical Research Institute, Randwick, NSW, Australia.lld:pubmed
pubmed-article:10051115pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10051115pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:10051115pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10051115lld:pubmed